Test of a Homeopathic Algorithm for COVID-19: the Importance of a Broad Perspective

Abstract

Background Most of the symptoms of coronavirus disease 2019 (COVID-19) are covered by large repertory rubrics and hence many remedies have been proposed as “genus epidemicus”. The aim of this study was to combine the information from various data collections to prepare a COVID-19 Bayesian mini-repertory/an algorithm-based application (app) and test it.

Methods In July 2021, 1,161 COVID-19 cases from 100 practitioners globally were combined. These data were used to calculate “condition-confined” likelihood ratios (LRs) for 59 symptoms of COVID-19. Out of these, 35 symptoms of the 11 medicines that had at least 20 cases each were considered. The information was entered in a spreadsheet (algorithm) to calculate combined LRs of specific combinations of symptoms. The algorithm contained the medicines Arsenicum album, Belladonna, Bryonia alba, Camphora, Gelsemium sempervirens, Hepar sulphuris, Mercurius solubilis, Nux vomica, Phosphorus, Pulsatilla and Rhus toxicodendron. To test concordance, the doctors were then invited to re-enter the symptoms of their cases into this algorithm.

Results The algorithm was re-tested on 358 cases, and concordance was seen in 288 cases. On analysis of the data, bias was noticed in the Merc group, which was therefore excluded from the algorithm. The remaining 10 medicines, representing 81.8% of all cases, were included in the preparation of the next version of the homeopathic mini-repertory and app.

Conclusion The Bayesian mini-repertory and app is based on qualitative clinical experiences of various doctors in COVID-19 and gives indications for specific medicines for common COVID-19 symptoms. It is freely available [English: https://hpra.co.uk/; Spanish: https://hpra.co.uk/es ] for further testing and utilization by the profession.

Keywords

COVID-19 - data collection - genus epidemicus - Bayesian repertory - homeopathic algorithm

Publication History

Received: 19 October 2021

Accepted: 19 January 2022

Article published online:
21 August 2022

• References

• 1 WHO Director-General's opening remarks at the media briefing on COVID-19, March 2020. Accessed September 14, 2021 at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
• 2 Hahnemann S. Organon of Medicine,. 6th ed.. New Delhi: B. Jain Publishers; 2004
• 3 Rutten L, Smedley T, Ives G. et al. Data collection during the COVID-19 pandemic: learning from experience, resulting in a Bayesian Repertory. Homeopathy 2021; 110: 94-101
• 4 Manchanda RK, Miglani A, Gupta M. et al. Homeopathic remedies in COVID-19: prognostic factor research. Homeopathy 2021; 110: 160-167
• 5 To KLA, Fok YYY. Homeopathic clinical features of 18 patients in COVID-19 outbreaks in Hong Kong. Homeopathy 2020; 109: 146-162
• 6 Rossi EG. The experience of an Italian public homeopathy clinic during the COVID-19 epidemic, March–May 2020. Homeopathy 2020; 109: 167-168
• 7 Manchanda RK, Miglani A, Chakraborty M. et al. Impact of bias in data collection of COVID-19 cases. Homeopathy 2021; 111: 57-65
• 8 Kahneman D. Thinking, Fast and Slow. London: Penguin books; 2011
• 9 Rutten L, Miglani A, Gold P. et al. Generalizability of homeopathic prognostic factor research outcome in COVID-19 treatment: comparison of data. Homeopathy 2022; 111: 157-163
• 10 Miglani A, Rutten L, Manchanda RK. Generalisability of prognostic factor research: further analysis of data from the IIPCOS2 study. Homeopathy 2017; 106: 155-159
• 11 Clapers ML, Velat M, Clapers JM, Vidal-Jové J, Mora J. Analysis of homeopathic genus epidemicus for COVID-19 patients in Spain. Homeopathy 2021; 110: 236-243
• 12 Reilly D, Mercer SW, Bikker AP, Harrison T. Outcome related to impact on daily living: preliminary validation of the ORIDL instrument. BMC Health Serv Res 2007; 7: 139
• 13 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
• 14 Vaishampayan S, Mutreja K, Lambe S, Shah J, Shaikh G. Mercurius solubilis as Genus Epidemicus for the COVID-19 pandemic. Homeopathy 2020; 109: 271-272
• 15 Collecting clinical experience of homeopathic support in COVID-19. LMHI newsletter 22. Bayesian analysis of symptoms, 18th issue; Published September 2021 at: https://www.lmhi.org/Documents/Covid19/LMHInewsletter22.pdf